06/02/2023 |
Department of Health & Human Services |
HHS-OIG Spring 2023 Semiannual Report to Congress |
Semiannual Report |
Agency-Wide |
03/16/2023 |
Department of Health & Human Services |
Medicare Advantage Compliance Audit of Specific Diagnosis Codes That Geisinger Health Plan (Contract H3954) Submitted to CMS |
Audit |
PA |
03/14/2023 |
Department of Health & Human Services |
Georgia Did Not Comply With Federal Waiver and State Requirements at All 20 Adult Day Health Care Facilities Reviewed |
Audit |
GA |
03/13/2023 |
Department of Health & Human Services |
Georgia Did Not Always Invoice Rebates to Manufacturers for Pharmacy and Physician-Administered Drugs |
Audit |
GA |
03/10/2023 |
Department of Health & Human Services |
Medicare Improperly Paid Physicians for Epidural Steroid Injection Sessions |
Audit |
MD |
03/03/2023 |
Department of Health & Human Services |
Florida Did Not Invoice Manufacturers for Some Rebates for Physician-Administered Drugs Dispensed to Enrollees of Medicaid Managed-Care Organizations |
Audit |
FL |
03/02/2023 |
Department of Health & Human Services |
State Agencies Did Not Always Ensure That Children Missing From Foster Care Were Reported to the National Center for Missing and Exploited Children in Accordance With Federal Requirements |
Audit |
US |
02/28/2023 |
Department of Health & Human Services |
Medicare Part D Plan Sponsors and CMS Did Not Ensure That Transmucosal Immediate-Release Fentanyl Drugs Were Dispensed Only to Beneficiaries Who Had a Cancer Diagnosis |
Audit |
US |
02/27/2023 |
Department of Health & Human Services |
Medicare Could Have Saved up to $216 Million Over 5 Years if Program Safeguards Had Prevented At-Risk Payments for Definitive Drug Testing Services |
Audit |
US |
02/27/2023 |
Department of Health & Human Services |
The Inability To Identify Denied Claims in Medicare Advantage Hinders Fraud Oversight |
Inspection / Evaluation |
US |